SLC5A2 and gout: First, all GLP-1 agonists do not affect blood urate levels.26 In contrast, studies reported some DPP4 inhibitors may inhibit blood urate levels.27,28 As a positive control in our study, DPP4 inhibitors may mitigate the SGLT2 inhibitor association with gout reduction.